Company / Tangible Book Value per Share
Stoke Therapeutics, Inc. Tangible Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.52
FY2025
5-year range
$3.47 / $6.52
FY2021-FY2025
Trend
+87.7%
vs FY2024
Sector context
#82 of 209
Health Care
What the data says
At $6.52, Stoke Therapeutics, Inc.'s tangible book value per share ranks #82 of 209 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 6 years of decline, reaching $6.52.
Based on SEC 10-K filings.
6.52 in FY2025 with a 5-year CAGR of -5.3%.
Improved from $4.69 to $6.52 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
#82 of 209 in Health CareTop 39% of 209This company $6.52 Sector average $93.47
▼
-93.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 87.7% year-over-year.
- Ranks #82 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
- Lowest tangible book value per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.52 | +87.7% |
| FY2024 | $3.47 | -25.9% |
| FY2023 | $4.69 | -20.6% |
| FY2022 | $5.90 | -0.4% |
| FY2021 | $5.93 | -30.6% |
| FY2020 | $8.54 | -31.6% |
| FY2019 | $12.49 | -91.6% |
| FY2018 | $148.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026